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I.

Introduction
The Idiopathic Respiratory Distress Syndrome of the newborn (RDS),

accounts for twenty percent of all neonatal deaths and claims 12,000
lives a yearJ

Great advances have been made in understanding the

pathogenesis of this disease, and new modalities of treatment and
methods of prevention have emerged from this understanding.

However,

much remains to be done and many infants continue to succumb.
The pathologic hallmark of RDS is generalized atelectasis,

2

and

if the infant lives longer than a few hours after birth, the classi¬
cal hyaline membrane can be demonstrated.

It is now believed that

the hyaline membrane does not cause atelectasis but is a secondary
finding resulting from tissue necrosis and the transudation of fibrin
and other plasma proteins into terminal bronchioles and alveolar
ducts.
In 1959 Avery and Mead

3

discovered that lung wash material from

infants that had succumbed to RDS lacked, or was deficient in, a
surface active substance that was present in the lungs of infants
that had died of non-pulmonary causes.

This surface active material,

or surfactant as it was called, has several important recognized
4
functions : it produces very low alveolar surface tension at end
expiration, thus preventing atelectasis at low lung volumes and de¬
creasing the pressure necessary to inflate the lungs; it produces a
stable balance between small and large alveoli thus preventing the
emptying of small alveoli into larger ones, as would otherwise occur
5
as predicted by Laplace's law. It is now a well accepted fact that
surfactant deficiency is the immediate etiologic factor that leads to

2

the development of RDS and that prematurity is the major predisposing
factor.
There exists controversy as to the exact composition of surfac¬
tant.

Most investigators agree that diaplmitoyl phosphatidylcholine
p C

c

(DPPC) ’ *

is the single most important component, since it is abun¬

dant in lung wash material from all mammalian species tested, and its
surface tension lowering properties are quite similar to those of
whole lung wash.

The Type II cell of the lung has been identified as
2 c

the site of surfactant synthesis * , and its osmiophilic inclusions,
"lamellar" bodies, believed to be the storage site for surfactant.^
The lung possesses the enzymatic machinery necessary for de novo

g
synthesis of DPPC .

Phosphatidic acid is converted to DPPC primarily

via the CDP-choline pathway which adds choline directly to phospha¬
tidic acid.

The alternate pathway of successive methylation of

phosphatidyl ethanol amine to produce DPPC does not seem to be of great
importance. The intracellular site of surfactant synthesis is not
definitely established, although it seems evident that the finished
product is accumulated in the lamellar bodies and then secreted into
the alveolar spaces.
During late gestation the fetal lung undergoes anatomical and
biochemical changes that prepare it for the gas-exchange functions
o

it must assume after birth.

Premature birth may mean that those

lung masturational changes have not had time to occur.

The incidence

of RDS is extremely rare after thirty seven weeks of gestation and
5
increases steeply with gestational age less than thirty five weeks .
The question naturally arises as to why a prematurely born infant does
not have enough surfactant at the alveolar-air interface.

Is it be-

.

.

.

■

-

;
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cause the surfactant has not been synthesized, or is the surfactant
present inside the Type II cells but fails to be released? Most
5
investigators hold the first view , although there have been re¬
ports that Type II cells from infants that have died of RDS contain
9
abundant lamellar bodies .

There is substantial evidence that cor¬

tisol enhances lung maturation and leads to increased surfactant
synthesis^0, but there is very little known about the secretion of

g
surfactant and its hormonal control.
One reason why understanding of surfactant secretion has been
lacking is that the Type II cells comprise only a small fraction of
the whole lung cell population, and therefore whole organ studies,
such as the ones in the thyroid, salivary glands or the liver, are
less revealing in the lung.

Isolated Type II cells have only recent¬

ly been obtained^, and studies on secretion are scant.
The cell line A549 was isolated from a human lung adenocarcinoma
and propagated in tissue culture.

It is genetically homogeneous and

should retain its properties in culture indefinitely.
choline into DPPC

It incorporates

12 13 14
* *
and has been shown by electron microscopy

to possess intracellular organelles that are strikingly similar to
lamellar bodies.

13

Type II pneumocyte

Therefore it has been considered a model for the
14

.

Although there are legitimate objections to

the study of differentiated cellular function in malignant cells,
previous experience with other systems such as the steroid secreting
Y1 adrenal tumor line
cell line

16

15

and the glucocorticoid sensitive hepatoma

have indicated that cells can retain differentiated func¬

tions in the neoplastic state.

12

It was for the above reasons, plus

the experimental versatility of a continuous cell line, that A549

'

•

4

was chosen for the study of surfactant secretion.
Since not much is known about secretion in the Type II cell the
underlying hypothesis was that its behavior could not be very differ¬
ent from other secretory systems.

Before concluding this introduc¬

tion, a few known facts about secretory processes in general will be
outlined.
1)

The contents of secretory granules are released from
cells (e.g. mast cells, chromaffin cells) by the mechanism
of exocytosis, in which the secretory granule fuses with
the cell membrane and discharges its product to the out17
side, leaving the cell membrane essentially intact.

2)

A hormone binding to its receptor on the cell surface
usually triggers a series of intracellular events that
leads to exocytosis^

3)

Changes in the intracellular concentrations of calcium,
cyclic AMP, cyclic GMP and changes in the state of the
microfilament-microtubule system result from the hor¬
mone binding to the receptor, and these changes in
turn initiate the process of exocytosis

4)

1 q 20

*

.

Artificial induction of these changes can stimulate
exocytosis bypassing the hormone-receptor interaction.
Thus theophylline and cAMP can directly activate the
adenyl cyclase system and calcium ionophores can in¬
crease the intracellular calcium ion concentration and
. 19
trigger exocytosis .

5)

Exocytosis results in the rapid release of stored

5

materials and over short time periods is independent
of active synthesis of the material to be released

19

.
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II.

Objectives of the Study
1)

To verify that the A549 cells actively incorporate choline
into disaturated phosphatidyl choline.

2)

To study the secretion of phosphatidylcholine by the
cells into the tissue culture medium.

3)

To study the effect of:
a.

Serum

b.

Theophylline

c.

cAMP

d.

Isoproterenol

e.

Carbamyl Choline

f.

Calcium ionophores

on the secretion of phosphatidylcholine.
4)

To determine the phospholipid composition of the cells
and of the secreted material.

5)

To assess the relevance of these studies to surfactant
secretion by Type II cells in vivo.

.

.
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III.

Experimental Section
Specific details of methodology will be presented in the Appen¬

dix, but a few words on the general experimental design of the secre¬
tion studies are presented here to enhance clarity.
( H)-choline was used as a radioactive label for surfactant,
since it is primarily incorporated by the cells into phosphatidycholine
(PC)

1314
* .

In some experiments

32

P was used (see Appendix I for de¬

tails of radioactivity measurements).

After a pulse of radioactive

precursor, the release of lipid extractable radioactive product iden¬
tifiable as PC in a thin layer chromatography (TLC) system was measur¬
ed. (See Appendix II)
Early in the study it became apparent that for a given set of cul¬
tures which had been grown together, and pulsed with the same amount
of radioactive precursor, the rate of release of PC into the medium
over consecutive one hour periods and under vasal conditions was
strikingly uniform and reproducible.

The following basic format was

adopted in the design of the secretion studies:
1)

Each plate was a control for itself in that release of
phospholipid over a one hour period under basal conditions
is compared to release over the ensuing one hour periods
in which conditions were changed.

2)

The first hour of release was called Phase I, the second.
Phase II etc.

3)

All the medium was removed at the end of each phase and
new medium added.

If the new medium contained no serum,

while the previous one did, the cells were washed two

8

times with medium without serum.
Details will be included with each experiment and methods that apply
to all experiments are presented in the appendices.

A.

Cell growth:
A549 cells were plated into 75 cm

2

plastic tissue culture flasks

6
2
at a density of 1 x 10 cells/flask and into 55 cm plates at a den5
sity of 7 x 10 cells/plate (see Appendix III for details of culture
techniques).

At the end of three weeks of incubation there were 12 x

r

r

10° cells/flask and 8.7 x 10
mately every other day.
and 890 mg. of DNA.

cells/plate, with medium changes approxi¬

A confluent flask contained 15 mg. of protein

A confluent plate contained 10 mg. of protein,

610 meg. of DNA, 0.94 uM of phospholipid phosphorus and 0.393 uM of
phosphatidylcholine phosphorus (see Appendix III).

B.

Morphology:
When first plated the A549 cells settle at the bottom of the

plate or flask and within one to two hours form strong attachments to
the plastic.

Shortly thereafter they completely cover the bottom of

the plate as a confluent monolayer, but these "early" cells are
characterized by cytoplasm largely devoid of lamellar bodies.

With

repeated medium changes, culture maturation is characterized by an
increasing number of cells/power field and therefore a concomitant
reduction in cytoplasm.

Numerous dark granules appear and three weeks

after plating these granules completely fill the cytoplasm and the
cells have achieved the smallest size they are capable of.

If medium

changes are continued, further growth is slow and characterized by the

.

•

■
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*

9

formation of "mounds" of cells, i.e. loss of the monolayer configura¬
tion.

This behavior is typical of transformed and malignant cells in

tissue culture.

The dark granules present in the cells have been prev¬

iously described by us as being strikingly similar to the lamellar
bodies of Type II pneumocytes

C.

13

.

,3 ,
( H)-choline incorporation and release from the A549 cells:
Four equally confluent plates of A549 cells were pulsed for

3
twenty four hours with 10 ml of F12K-FCS containing 3 yCi/ml of ( H)3
choline. 46% of the ( H)-choline was incorporated into the cells
during this twenty four hour period.
The cells from two plates were collected immediately after the
pulse, the lipid extracted and analyzed by TLC.

43.6% of the intra¬

cellular radioactivity was lipid extractable and 90% of this was re¬
covered in the PC fraction from the silica gel; the remaining counts
were in the lysolecithin and sphingomyelin fractions.
The other two plates were washed three times with F12K-FCS to
remove all the unused ( H)-choline and incubated in 8 ml of non-radio¬
active F12K-FCS for twenty four hours, the medium was collected and
8 ml of fresh medium added.

This procedure was repeated at 24, 48, 72,

96 and 120 hours after the end of the pulse.
the medium and aliquots analyzed by TLC.

Lipid was extracted from

I

t

:

10

TABLE 1
Results are the average of two plates
Hours

Total CPM in Lipid
Extract of Medium

Total CPM in
PC Fraction

24

91450

66828

48

103320

80589

72

92010

65721

96

81110

62025

120

73110

54832

These results indicate that the A549 cells can actively incor¬
porate radioactively labelled choline into PC and release it into the
medium in quantifiable amounts.

D.

Phospholipid Composition of the A549 Cells:
The phospholipid composition of the A549 cells has been previous¬

ly determined by lipid extraction and fractionation by TLC^.

Individ¬

ual phospholipids were eluted from the gel and quantitated directly
by phosphorous assay.

This method is accurate but laborious and cannot

be applied to material secreted into the tissue culture medium since
small quantities are secreted and the presence of phospholipids from
the medium would contaminate the assay.

A technique of isotope

equilibration was thus used to measure the phospholipid composition of
A549 cells.
the cells to

The assumption was made that after prolonged exposure of
32

P, the concentration of the isotope in all the intra¬

cellular phosphorous pools would be the same and measurement of the

0:

>

•

11

radioactivity in each of the phospholipids should reflect the rela¬
tive concentration of that phosopholipid.
A549 cells were plated and incubated as usual in F12K-FCS.
week after plating

32

One

P was added to the tissue culture medium to a con¬

centration of 20 yCi/ml and medium changes with this radioactive
medium were continued every two days for two weeks.

The cells were

washed three times with Earle's Basic Salt Solution plus calcium,
scraped off the plates, sonicated and phospholipid extracted.

The

phospholipid extract was fractionated by TLC in chloroformrmethanol:
acetic acid:water, 50:35:4:2.

The following phospholipid composition

was obtained (average of three identically treated plates, variation
from plate to plate was less than 2%).
obtained by phosphate determination

21

The phospholipid composition
is included for comparison.

TABLE 2
32

Phospholipid

(

P) equilibration

Phosphorous
assay

Lysolecithin

1.13%

2.2%

Sphingomyelin

7.3%

6.3%

Phosphatidylcholine

44.6%

41.3%

Phosphatidyl serine &
phosphatidyl inositol

11.2%

14.2%

Phosphatidylethanol amine

22.2%

28.0%

Phosphatidylglycerol &
cardiolipin

10.9%

6.4%

Equilibration of A549 cells with

32

P for two weeks to determine

phospholipid composition leads to results that are quite similar to

.f

12

those obtained by direct analysis of the phospholipid extract.

This

method will be subsequently applied to analysis of secreted material
and could be of great usefulness in analyzing subcellular fractions in
which small amounts of phospholipids are present.

E.

Effect of Serum on Phospholipid Release:
It is known that phospholipids can exchange between serum lipo-

proteins and cell membranes both in vivo and in vitro.

22 23 24
* *

In a

system such as this one where cellular phospholipids are radioactively
labelled and their release into the medium measured such exchange can
mimic net secretion.

For this reason the following experiment was de¬

signed to study the effect of removing serum on the amount of phospho¬
lipid released from A549 cells in culture.
Three equally confluent plates were pulsed with ( H)-choline for
twenty four hours, all plates were then washed three times with
Solution D and incubated two hours in F12K-FCS, all medium was re¬
moved and each plate was treated as follows:
Plate 1 was incubated in 5 ml of F12K-FCS for one hour periods four
times.
Plate 3 was incubated in 5 ml F12K-FCS the first hour, in F12K the
second and third hour and in F12K and albumin (50mg/ml) the
fourth hour.
Plate 2 was incubated in F12K-FCS the first hour, in F12K the second,
third and fourth hours and in F12K-FCS the fifth hour.
All media were collected at the end of each one hour period, the lipid
3
extracted and the amount of H labelled lipid recovered from the

.

•

.

. .
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medium measured

TABLE 3
Plate

Hour Period
I

II

III

IV

1

S-5355

S-5402

S-5312

S-5327

2

S-5407

0-1630

0-813

0-502

3

S-5272

0-1582

0-781

A-4309

V

S-4987

3
Results are CPM of ( H)-lipid recovered from the medium at the end of
each hour period.

"S," "0," "A" indicate whether serum was present (S),

absent (0) or whether albumin was added (A).

These results are also

plotted in fig. 1.
It is clear that a marked reduction in the level of ( H)-labelled
phospholipid recovered from the medium occurs upon removal of the serum,
and that this effect can be reversed by the re-addition of serum or
high albumin concentration to the medium.

From this point on the

serum mediated release will be called phospholipid exchange and any
non-serum mediated release will be termed secretion.
F.

Effect of Theophylline, Cyclic AMP, Carbamyl Choline and Isopro¬
terenol on Phospholipid Secretion:
The possibility of increasing surfactant secretion in the A549

cells by stimulating the adenyl cyclase system, or by stimulating
adrenergic and cholinergic receptors was studied.

■»

'

. ..
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3
Nine confluent plates were pulsed with ( H)-choline, the cells
were washed three times with Solution D at the end of the pulse and
incubated two hours in F12K-FCS.

This medium was removed and discard¬

ed and all the plates incubated for one hour in F12K-FCS (Phase I).
Each plate was incubated a second hour (Phase II) in F12K-FCS with
or without addition of the substances being tested.

TABLE 4
Results are 3H CPM in lipid extract of medium collected at the end of
each hour
Plate

I

1

2353

2

2319

3

2411

4

2513

5

2427

6

2428

7

2501

8

2462

9

2362

ADDITION
none
10 3M Theophylline
ll

lo"3M cAMP
II

10

-4

M Isoproterenol
ll

10

-4

M Carbamyl Choline
II

II
2521
2483
2302
2602
2493
2648
2572
2511
2417

Under these conditions, theophylline, cAMP, isoproternol and
carbamyl choline were without effect on secretion.

.

/
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Figure 1:

Effect of Serum on Phospholipid Release

HOUR

3

Each point represents CPM of

H labelled phospho¬

lipid released into the medium during each one hour
incubation.

Sequences 1, 2 and 3 represent plates

1, 2 and 3 respectively.

Plate 1 was incubated in

10% serum through four straight one hour periods.
Plate 2 was incubated in serum the first hour, with¬
out serum the 2nd, 3rd and 4th hours and again in
serum the fifth hour.

Plate 3 was incubated in

serum the first hour, without serum the second and
third hours, and in albumin (50 mg/ml) the fourth
hour.

See Table 3 for further details.

■
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G.

Studies with Calcium Ionophores A23187 and X537A:
Calcium ionophores are lipid soluble substances of microbiologi¬

cal origin that have the ability to bind calcium at relatively high
concentrations, diffuse across lipid barriers such as cell membranes
and release the calcium if the intracellular concentration of the ion
is sufficiently low

19 25
* .

Since most cells that synthesize and

store a product for secretion need a rapid influx of calcium for
exocytosis to take place

19

, the calcium ionophores provide an inval¬

uable tool for determining if a given cell population is capable of
secreting the substance in question following a calcium stimulus.
Increasing the extracellular calcium concentration will not usually
initiate exocytosis since the cell membrane is relatively impermeable
to calcium and an active calcium pump at the membrane maintains a
concentration gradient with the intracellular concentration being
several orders of magnitude lower than the extracellular

19

.

The

effect of two calcium ionophores, A23187 and X537A were thus studied.
(See Appendix IV for details of ionophore preparation).
1.

Effect of ionophores on secretion (medium containing serum)
3
Five plates were pulsed with ( H)-choline for twenty four hours
in F12K-FCS, the medium was removed and discarded and the plates
incubated two hours in F12K-FCS, this medium was again discarded
and the cells incubated for two consecutive one hour periods in
F12K-FCS with the ionophores being added in the second hour.
The medium was collected at the end of each hour period and
analyzed.

,

17

TABLE 5
3
Results expressed at ( H) CPM in PC released into the medium during
each one hour period

(first hour)

PLATE
1

10108

2

10821

3

9973

4

9950

5

10057

2.

ADDITIONS

II (second hour)
9991

none

26927

A23187 (10 mcg/ml)
II

29216

X537A (20 mcg/ml)

16915

II

17096

Effect of ionophores in the absence of serum:
Three plates were pulsed as above and incubated for two hours

in F12K-FCS.

Each plate was then washed three times with F12K and

incubated for two consecutive one hour periods in F12K (5 ml) with
ionophore addition being made during the second hour period.

All

media were collected at the end of each hour and analyzed.

TABLE 6
PLATE

I(first hour)

1

1410

2

1427

3

1381

results are
3.

33

....

.

ADDITIONS
none

II(second hour)
1091

A23187 (lOmcg/ml) 15213
II

_

15021

H CPM in PC released into the medium during each hour.

Effect of EDTA on response to ionophores:

18

3

Six plates were pulsed with ( H)-choline as above and incubated
for two hours in F12K-FCS, each plate was then incubated for two con¬
secutive one hour periods with ionophores and EDTA being added in the
second hour.

All media were collected at the end of each hour and

analyzed.

TABLE 7
Results expressed as JH CPM in PC released into the medium during
each hour period
PLATE

I(first hour)

1

10802

2

10770

3

10007

4

10384

5

10608

6

10556

ADDITIONS

II(second hour)

none

11152

A23187(10mcg/ml)

27020

" & EDTA (2.5mM) 11705
X537A(20mcg/ml)

19864

" & EDTA (2.5mM) 17904
EDTA (2.5 mM)

10375

These results are plotted in figure 2.

4.

Dose response curve to A23187:
Other investigators have reported that magnesium can inhibit

the effect of the ionophore A23187

19

.

I tested this hypothesis on

our system, and indeed, found that higher responses could be obtained
if the medium did not contain magnesium.

For this reason the follow¬

ing experiment was carried out in Earle's Basic Salt Solution with
ImM calcium but no magnesium, serum was also omitted to minimize phos¬
pholipid exchange and optimize conditions for secretion.

.

19
Figure 2:

Effect of EDTA on Response to Ionophores

HOUR

Each point represents CPM of

3

H labelled phospha¬

tidylcholine released during each hour of incuba¬
tion.

During the first hour (I) all the plates

were incubated under basal conditions and during
the second hour (II) ionophores and EDTA were added.
Lines 1-5 represent plates 1-5.

During the second

hour (II) plate 1 received no additions, plate 2
received A23187, plate 3 received A23187 plus EDTA,
plate 4 received X537A, plate 5 received X537A
plus EDTA.

See Table 7 for further details.

.
)

'UJ
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3
Seven confluent cultures were pulsed with 30 yCi of ( H)-choline
in 10 ml of F12K-FCS for twenty four hours, each plate was then incu¬
bated for two hours in 10 ml of EBSS with calcium and 10% fetal calf
serum, washed three times with EBSS-Ca and incubated for two consecu¬
tive one hour periods in 5 ml of EBSS-Ca, different concentrations of
ionophore were added in the second hour.

All media were collected at

the end of each one hour period and the phosphatidylcholine measured.

TABLE 8
PLATE

I(first hour)

ADDITIONS
(A23187 mcg/ml)

II(second hour)

1

1697

0

637

2

1513

0.1

1452

3

1602

0.3

2307

4

1713

1.0

3405

5

1681

3.0

8715

6

1653

10.0

34697

7

1612

30.0

99097

Results are CPM of

3

H in phosphatidylcholine extracted from the

medium at the end of each one hour incubation.
These results are plotted in figure 3.
Observation of the cells under the microscope within minutes
after the addition of A23187 (3 and 1- mcg/ml) revealed a marked
diminution in the number of intracellular granules.
These experiments show that both X537A and A23187 cause a marked
and rapid release of phosphatidylcholine into the medium both in the

.
.
.

21

presence and the absence of serum.
PC was disaturated (DPPC).

Forty five percent of the released

(See Appendix II for details of lipid analy¬

sis).
The experiments with EDTA show that chelation of calcium abolish¬
es the response to A23187 but not to X537A.

The experiments with EDTA

were also performed in the absence of serum and the same result was
obtained.

22

Dose Response Curve to A23187

CPM xlO

Figure 3:

J

I

I

I

I

l

O.l

0.3

1.0

3 0

10

30

A 2 318 7 (mcg/ml)

Each point represents CPM of

3

H labelled phosphatidylcholine

released into the medium after stimulation of each of six
plates with A23187 at different concentrations minus the
CPM released by an unstimulated plate.
for details.

See text and Table 8

xre

.
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5.

Effect of A23187 on release of intracellular contents:
To determine if the increase in phospholipid release caused by

A23187 was due to damage to the cells and a non-specific release of
intracellular contents, four confluent plates were incubated for one
hour (Phase I) in EBSS with calcium, and then one hour (Phase II) in
EBSS with calcium and A23187 (10 mcg/ml).

All the media were collected

at the end of each hour and the activity of Lactic Dehydrogenase re¬
leased into the medium assayed.

TABLE 9
Results expressed as LDH International Units released into the medium
during each hour period. Results are average of four plates.
Phase I

Phase II

18

18

Lysing the cells by incubating them in hypotonic solution caused the
release of over 1000 LDH units.
As an additional control the release of free amino acids into
the medium was also determined and these results also indicated no
significant loss of intracellular contents following stimulation
with A23187.
6.

Phospholipid composition of secreted material:
The percent composition of the different phospholipid classes

was determined for the secreted material by a method similar to the
one described for the phospholipid composition of the whole cells.
Four plates were allowed to reach confluence by incubating them for
three weeks in F12K-FCS containing 20 yCi/ml of

32

P. Medium changes
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were done every two days.

At the end of three weeks each plate was

washed three times with F12K and then incubated two hours in F12K-FCS
without the radioactive precursor.

Each plate was then washed three

times with EBSS-Ca and incubated for one hour in 5 ml of EBSS-Ca
(Phase I).

The media were collected and 5 ml of EBSS-Ca containing

A23187 (5 mcg/ml) were added to each plate.

All media were collected

at the end of each hour, the lipid was extracted and analyzed by TLC.
Individual spots were scraped off the silica gel and counted by liquid
scintillation.

TABLE 10
32
Results are expressed as
P CPM in each phospholipid class released
into the medium. Percentages were calculated by dividing the CPM for
each phospholipid by the total CPM in phospholipid released during each
hour.
Phospholipid

Phase I
CPM

%

Phase II
CPM

%

Lysolecithin

260

3.6%

2883

3.4%

Sphingomyelin

673

9.2%

13010

15.5%

2601

35.4%

35654

42.4%

665

9.1%

8121

9.7%

1910

26.6%

15645

18.6%

742

10.1%

3348

3.9%

Phosphatidylcholine
Phosphatidylserine &
phosphatidylinositol
Phosphatidylethanol amine
Phosphatidyl glycerol &
cardiolipin

Each result is the average of four plates.

The phosphatidyl choline

fraction from the Phase II material (stimulated secretion) was further
analyzed by the procedure of Mason and found to be 46% disaturated
(DPPC).

-

*
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The results show that A23187 causes a marked increase in the
secretion of all phospholipid classes, with a selective enrichment in
the sphingomyelin and phosphatidylcholine fractions, and a relative
decrease in the phosphatidylethanolamine and phosphatidylglycerol.

26

IV.

Discussion
The above experiments were designed to evaluate the A549 cell

line as a model for surfactant secretion by the Type II pneumocyte.
We

13

have previously shown that the A549 cells, when fully confluent,

are rich in lamellar bodies, the morphologic hallmark of the Type II
cell.

We also showed that sixteen percent of the phosphatidycholine

in the cells is disaturated (DPPC), but this figure is thirty nine per¬
cent when the lamellar bodies are isolated and analyzed.

The phos¬

phatidylcholine secreted by the cells into the tissue culture medium
is forty six percent disaturated.

For comparison. Type II cells

isolated from rabbits have fifty point five percent disaturated PC,
and PC from human lung lavage is fifty four percent disaturated

21

.

The figures for whole cell disaturated PC are relatively low, but a
marked enrichment is seen when the lamellar bodies and the secreted
material are analyzed.

The similarity between the disaturated PC

in lamellar bodies and secreted material in the A549 cells suggests
that the secreted material is coming from the lamellar bodies. The
3
cells actively incorporate H-choline into PC and DPPC. This combined
with their rapid growth in tissue culture and the above mentioned
similarities with the Type II cell made them an attractive system in
which to look at surfactant secretion.
Before looking at ways to stimulate secretion, it was necessary
to determine if phospholipid exchange between the cells and the serum
was occurring.

We showed that changing from ten percent fetal calf

serum to no serum caused a rapid and marked decrease in the amount of
3
H labelled lipid recovered from the medium; this effect could be

27

rapidly reversed by the readdition of serum or a high concentration
of albumin to the medium.
It had been previously reported

14

that carbamyl choline and

isoproterenol stimulate phospholipid secretion in the A549 cells, I
tested these agents on the cells and obtained no response.

To test

tf stimulation of the adenyl cyclase system could increase secretion,
cAMP and theophylline were tested, and no response was obtained.
Calcium is known to stimulate exocytosis by secretory cells,
and a calcium influx hypothesis of stimulus secretion coupling has

g
been proposed .

Calcium ionophores are natural antibiotics that pro¬

duce an influx of calcium into cells, and have been shown to stimulate exocytosis in multiple systems

19

.

The ionophores A23187 and

X537A, were tested and were found to markedly stimulate PC secretion
both in the presence and in the absence of serum, indicating that
phospholipid exchange was not involved.

The effect of A23187 could

be blocked by EDTA and was actually enhanced by removing magnesium
from the medium, indicating that it was calcium mediated.

EDTA

alone produced no change in the serum dependent release, again
separating phospholipid exchange from calcium induced secretion.
effect of X537A was not blocked by EDTA.

The

The reason for this dis¬

crepancy can be explained from the fact that A23187 can only bind
divalent cations while X537A can also bind sodium and potassium.
Since the ionophores can only enter the cell when complexed with an
ion, in the presence of EDTA A23187 cannot enter the cell while X537A
can still enter complexed with sodium or potassium. Once inside the
cell

X537A can liberate calcium from mitochondria, which are known

to be rich in calcium.

19

■
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The response to A23187 was dose dependent and the range of
responsiveness is similar to that reported in other systems

19

Following stimulation with ionophores a marked diminution in the
number of intracellular granules could be observed.
That the release of phospholipids was not due to leakage of
intracellular contents from cellular damage was indicated by the
lack of release of free amino acids and of the intracellular enzyme
lactic dehydrogenase following stimulation with the ionophore.
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V.

Conclusion

The A549 cell line had been considered a model for the Type
II cell.

Two new properties of this cell line have been discovered

and described here:

1) A phospholipid exchange process between cellu¬

lar and serum phospholipids has been demonstrated.

2)

Calcium

dependent exocytosis is one mechanism by which disaturated phospha¬
tidylcholine is released from cells.

Extrapolation of these results

to Type II cells in vivo remains to be shown. Nevertheless, these
findings are very relevant to current experimental study of the pul¬
monary surfactant system.

Subsequent investigation of physiologic

secretagogues may have therapeutic implications for RDS.

APPENDIX
Detailed Methodology
Materials
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APPENDIX I
Radioactive Labelling and Liquid Scintillation Counting
Cells were plated at a density of 10

cells/plate and brought

to confluence with medium changes (complete medium), every other day
for three to four weeks. They were then pulsed with 30 uCi of ( H)choline (methyl
four hours.

H, 4.3 Ci/mmol.), in 10 ml. of F12K-FCS for twenty

Each plate was then washed three times with 10 ml of

Solution D to remove as much as possible of extracellular radioactive
material. Each plate was incubated for two hours in 10 ml. of F12K-FCS
and then washed once before beginning any secretion studies.
32
Labelling with
P is described in the appropriate experimental
sections.
Counts

per minute on radioactive samples were determined by

liquid scintillation counting (LSC), in vials containing 0.5 ml. of
water and 14.5 ml. aquasol (NFN).

Counting was performed in a Beckman
3
LS 100C Liquid Scintillation Counter. Efficiency of H counting was
determined with known reference standards.
3

( H)-choline labelled phospholipids were counted by placing
lipid extract in ChCl^ in an LSC vial, drying under N^, adding 0.5 mis.
of H^O and 11.5 ml. aquasol, vortexing and then counting. Specific
3
H choline labelled phospholipid from TLC silica gels were counted
by placing the scraped spot from the TLC plate in an LSC vial, add¬
ing 0.5 ml. H20 and 11.5 ml. aquasol, vortexing the vial vigorously
and allowing them to sit for twenty-four hours to allow for maximal
elution of the phospholipid from the silica.

,j, jj

.

.

32

32

P labelled phospholipid from either lipid extracts or silica

gels were counted by the same procedure as for
and

32

P were counted in appropriate channels.

3

H-choline.

3

H-choline

A blank was always in¬

cluded with each set of samples and the background CPM were substracted from all results.
The efficiencies of counting were determined with known reference
standards and were as follows:

Isotope

Scintillation Mixture

Efficiency

lipid residue

H^OrAquasol, 0.5:14.5

31

on silica gel

H^Aquasol, 0.5:14.5

22

lipid residue

k^O^quasol, 0.5:14.5

100

on silica gel

H^Aquasol, 0.5:14.5

100

Medium

%

33

APPENDIX II
Lipid Analysis
A.

Collection of Medium Samples for Analysis:
Culture medium for analysis was removed from plates by pipetting.

If the medium did not contain serum, enough FCS serum was added after
collection to make it 10% FCS, this 10% dilution factor was always
corrected for in any measurements made on such samples.
Each medium sample was then centrifuged at lOOOg's for ten
minutes and the supernatant saved for analysis.

B.

Lipid Extraction (procedure of Bligh and Dyer):

27

Lipids from sonicated cell suspensions or from tissue culture
media in secretion studies were extracted in glass tubes by adding
chloroform and methanol with a final ratio of chloroform:methanol:
water of 1:2:0:8.

This mixture was vigorougly vortexed for two

minutes and a monophasic system obtained.

The monophasic system was

then centrifuged at 20Q0g's for twenty minutes and the pellet ob¬
tained is discarded, it contained insignificant amounts of lipid.
Chloroform is then added to the monophasic mixture to a ratio of
2:2:0.8, chloroform:methanol:water, and the tube is vigorously vottexed for thirty seconds. Water is then added to a final ratio of
2:2:1.8, and the tube again vortexed for thirty seconds.

After cen¬

trifuging for twenty minutes at lOOOg's a sharply separated two phase
system is obtained with practically 100% chloroform-lipid at the
bottom and methanol-water at the top.

The chloroform layer is then

carefully removed and transferred to separate tubes and stored at

■

'
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-20°C until ready for analysis.

C.

Thin Layer Chromatography:

2i 28

*

Radioactive lipid extracts were analyzed by thin layer chromato¬
graphy on Kontes/Quantum Pre-adsorbent Silica Gel TLC plates, (20 x 20
cm., 19 channels, 250 u thickness).
Solvent systems used for development were:

chloroform:methanol:

10.5N NH^OH, 60:35:8; chloroform:methanol:acetic acid:water, 50:35:4:2.
Individual samples were spotted on each channel in small volumes
(25-50 mcl.) of chloroform and the plates were then allowed to run
until the solvent front reached the top.

The plate was then removed

from the developing tank, allowed to dry, and the spots were visualized
in a tank saturated with iodine vapor.

Individual spots were scraped

off with a surgical blade and transferred to liquid scintillation vials
for counting. Known phospholipid standards were run with and alongside
the samples to obtain better visualization in the iodine tank.

D.

The percent disaturated phosphatidylcholine was determined by the
method of Mason

29

.
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APPENDIX III
Tissue Culture Methods
A.

Culture Techniques:

The A549 cell line is maintained as a monolayer culture in
2
75 cm. plastic tissue culture flasks in 14 ml. F12K medium with 10%
heat inactivated fetal calf serum, and containing 100 units/ml.

Peni¬

cillin G, 100 mcg/ml. Streptomycin and 0.25 mcg/ml. Fungizone.

The

cells were incubated at 37°C under 95% air and 5% CO^ in a humidified
incubator.

B.

Definition of Tissue Culture Media Used:

F12K

-

F12K medium (Gibco)

FCS

- Fetal calf serum, heat inactivated (Gibco)

F12K-FCS -F12K 90% and FCS 10%
EBSS

- Earles Basic Salt Solution, a phosphate and bicarbonate
buffered saline solution, pH 7.4, without calcium or
magnesium.

When calcium was added (ImM) it will be indicated

as EBSS-Ca.
Solution D - Puck's Solution D, a phosphate buffered saline, pH 7.4
Complete medium-F12K-90%, FCS-10%, Penicillin G-100 U/ml.,
Streptomycin-100 meg./ml., Fungizone-0.25 meg./ml.
C.

Subculturing Technique:
Subculturing was performed by treating a confluent 75 cm.

2

flask

with 5 ml. of 0.2% trypsin in phosphate buffered saline at a pH of

'
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7.4 for 10-20 minutes at room temperature. The flask was shaken for
10-20 seconds every two minutes until the cell monolayer came off in
sheets.

The sheets were then broken up by pipetting up and down with

a 10 ml. pipette until a fine cell suspension was obtained (single
cells or clumps of 2-4 cells each).

The contents of a 75 cm.

2

are

2
split 1:10 if transferred to 75 cm. flasks and 1:14, if transferred
2
to 55 cm. plates. A medium change was always done twenty-four hours
after subculturing and every two to three days thereafter.
Cell numbers were determined by counting at least 400 cells
with a hemocytometer, and viability was determined by trypan blue dye
, . 30
exclusion .
Morphologic observations were made by phase contrast microscopy.
D.

Collection of Cells:
Cells for DNA, proteins, or lipid studies were obtained by

scraping with a rubber policeman in phosphate buffered saline, pH
7.4, at 4°C.

The cell suspension was then sonicated at a setting of

30 Watts for 10 seconds at 4°C.

The cells were sonicated three times

with one minute intervals in between sonication to maintain a low
temperature.
E.

Protein and DNA Determinations:
Protein content of sonicated cell suspension was determined by

the method of Lowry

31

, with BSA used as a standard.

DNA content was

determined by a modification of the method of Burton with Calf Thymus
DNA as a standard

32

.
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F.

Phosphate Determination:
Phosphate determinations on whole cell lipid and phosphatidyl -

choline extracts were performed by the procedure of Bartlett

33

.
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APPENDIX IV

Preparation of Ionophores A23187 and X537A:

X537A was dissolved in pure ethanol at a concentration of 2 mg/ml
and added directly to the plates in experiments.

A23187 was prepared

by mixing 10 mg. of A23187 and 100 mg. of PVP (Polyvinyl Pyrrolidone)
in a small volume of chloroform, the mixture was dried under vacuum
and redissolved in 2 ml. of pure ethanol.

On the day of an experiment

the ethanol solution was diluted 1:10 with distilled water and approp¬
riate volumes added directly to the plates.
Both X537A and A23187 exist as microsuspensions in aqueous media,
and filtering of such solutions through micropore filters leads to
loss of ionophore activity.
Appropriate controls with PVP and ethanol were run in several
of the experiments and at the concentrations used, these agents were
without effect.

39

APPENDIX V
Materials
The A549 cells were provided by Dr. A. Gadzar of the National
Cancer Institute, the cells had been previously grown in RPMI medium,
but were successfully adopted to F12K-FCS upon receipt in our labora¬
tory.

The cells were received at passage 20 and all the studies re¬

ported here were performed on cells with passage numbers 28-35.
Tissue culture media, serum, and antibiotics were purchased from Grand
Island Biologicals Company (GIBCO), the fetal calf serum was heat
inactivated and was all from the same lot.

Tissue culture flasks

were purchased from Corning and plates from Falcon.
Chloroform and methanol, reagent grade, were purchased from
Mai 1inckrodt; Ammonium hydroxide and acetic acid (glacial) were pur¬
chased from Baker.

Thin layer chromatography plates were purchased

from Kontes/Zuantum, phospholipid standards were purchased from
Analabs.
A23187 was a gift of Eli Lilly and Co. and X537A was a gift
from Hoffman LaRoche.

Carbamyl Choline, isoproterenol, theophylline,

dibutiryl cyclic AMP, bovine albumin and EDTA were purchased from
Sigma.

Polyvinylpyreolidone (MW 40,000,pharmaceutical grade) was

purchased from GIBCO.

Radiochemicals and aquasol were purchased

from New England Nuclear.
formed on a Beckman LS100C.

Liquid scintillation counting was per¬
Sonication of cells was performed on a

Bronson Sonic Power Co. Model W185 Sonifier Cell disruptor.

.

'

.
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